BioSpace News Archive

Oncoustics Closes New Funding to Advance its AI Innovations in Ultrasound and Address Huge Unmet Clinical Needs in Liver Disease

Oncoustics ( http://www.oncoustics.com ), the leader in ultrasound-based tissue characterization solutions announces the initial close of a $5 million+ seed round of funding to advance its SaMD (software as a medical device).

July 21, 2022
·
4 min read
Business

Artizan Biosciences Announces Multi-Year Research Collaboration with the University Medical Center Utrecht and Microviable Therapeutics

Artizan Biosciences, Inc. today announced that it has entered into a multi-year research collaboration with the University Medical Center Utrecht (“UMC Utrecht”) in The Netherlands and Microviable Therapeutics.

July 21, 2022
·
5 min read
Business

BridgeBio Pharma Announces Academic Collaboration with Baylor College of Medicine to Advance Potential Therapies to Treat Genetic Diseases

BridgeBio Pharma, Inc. today announced a new collaboration with Baylor College of Medicine to identify and translate cutting-edge research into potential therapies for patients with genetic diseases.

July 21, 2022
·
4 min read
Business

iSpecimen to Report Second Quarter 2022 Results on August 4, 2022

iSpecimen Inc. today announced that it will report its financial results for the second quarter ended June 30, 2022, before the markets open on Thursday, August 4, 2022.

July 21, 2022
·
3 min read
Drug Development

Sonnet BioTherapeutics Announces Clinical Trial of SON-1010 in Healthy Volunteers

Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that a second Phase 1 clinical trial of SON-1010(IL12-F H AB) has been authoriized.

July 21, 2022
·
6 min read
Drug Development

Incannex Receives Ethics Approval to Commence Phase 1 Clinical Trial of Multi-Use Anti-Inflammatory Drug IHL-675A

Incannex Healthcare Limited is pleased to announce that it has received approval from the Bellberry Human Research Ethics Committee (‘HREC’) for a phase 1 clinical trial investigating its proprietary multi-use, anti-inflammatory drug IHL-675A.

July 21, 2022
·
8 min read
Business

Collegium to Report Second Quarter 2022 Financial Results on August 4, 2022

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that it will report second quarter 2022 financial results after the market closes on Thursday, August 4, 2022.

July 21, 2022
·
1 min read
Business

OrthoPediatrics Corp. to Report Second Quarter 2022 Financial Results on August 4, 2022

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that the Company is scheduled to release its second quarter 2022 financial results on Wednesday, August 3, 2022, after the market closes.

July 21, 2022
·
1 min read
Global Biomedical Textiles Demand Is Forecast To Surge At A CAGR Of 5% Through 2032, States Fact.MR

Fact.MR – A Market Research and Competitive Intelligence Provider: The global market for biomedical textiles surged at a CAGR of 4% from 2017 to2021.

July 21, 2022
·
7 min read
Skin Rejuvenation Market to Incur Rapid Extension During 2021-2031

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global skin rejuvenation market is projected to expand at a promising rate from 2021 to 2031.

July 21, 2022
·
7 min read